Cancer Biology Pathway


The Cancer Biology Pathway program is designed to train pre- and postdoctoral students in interdisciplinary research relevant to cancer biology. The goal of the program is to provide basic scientists an in depth training in diverse aspects of basic, translational, and clinical cancer research. During the two year program, trainees take part in an a didactic course in Molecular Oncology each spring semester.


Tuesday, Noon-1:30 PM
11th Floor Mid-Campus Center, Main Conference Room (unless otherwise noted)

2018-2019 Academic Year

Date Speaker Title
Jan 15, 2019
FLTC 204
Jeff Magee, MD, PhD Development and Pediatric Cancer
Jan 22, 2019
11th Floor MCC North
Dave Wilson, MD, PhD Bone Marrow Failure Syndrome Associated Leukemia Predisposition
Jan 29, 2019 Jeff Bednarski, MD,PhD DNA Damage and Cancer
Feb 5, 2019
FLTC 204
Todd Fehniger, MD, PhD NK Cell Immunotherapy
Feb 12, 2019 Todd Druley, MD, PhD Cancer Predisposition or Minimal Residual Disease
Feb 19, 2019 Laura Schuettpelz, MD, PhD Inflammation and Myeloid Malignancies
Feb 26, 2019 Gavin Dunn, MD, PhD Brain Tumors and Neoantigen-Directed Immunotherapy
Mar 5, 2019 Brian Van Tine, MD, PhD Tumor Metabolism
Mar 12, 2019 Sima Bhatt, MD
Mar 19, 2019 TBD
Mar 26, 2019
11th Floor MCC North
Samantha Morris, PhD Developmental Reprogramming
Apr 2, 2019 Christopher Sturgeon, PhD In Vitro Model of Development and Malignancy
Apr 9, 2019 Grant Challen, PhD Epigenetic Regulation of Stem Cell Self-Renewal and Leukemia Initiation
Apr 23, 2019
Holden Auditorium (FLTC)
Trevor Pugh, PhD
University of Toronto
Invited Speaker
Precision Medicine at Single Cell Resolution